By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Asthma symptoms can be managed and lung function can be improved with the use of the drug combination formoterol budesonide.
It is prescribed when a patient’s asthma cannot be adequately controlled by other asthma medications or when the patient’s condition is so severe that multiple medications must be taken daily. Taking this medication after an asthma attack has already begun will not help.
Additionally, the administration of this medication prevents the progression of chronic obstructive pulmonary disease and treats airflow obstruction (COPD). This includes emphysema and chronic bronchitis.
Budesonide for inhalation is a member of the corticosteroid drug class (cortisone-like medicines). It functions by reducing the inflammation (swelling) that leads to an asthma attack in the lungs.
Formoterol is a member of the bronchodilator drug class and is inhaled. It functions by assisting the muscles surrounding your lungs’ airways to maintain their relaxed state, thereby preventing asthma symptoms like wheezing and shortness of breath. As a result, the bronchial tubes may move more air.
This medication is taken via oral inhalation. Shake vigorously before use. After using, rinse your mouth with water. Be careful not to ingest the water. Follow the dosage instructions on the medicine package.
Don’t use it more frequently than recommended. Up until your doctor instructs you to stop, keep taking it. Store between 20 and 25 degrees Celsius at room temperature (68 and 77 degrees F).
Keep your inhaler out of the heat, the cold, and the humidity. This medication burns easily. Refrain from being around heat, fire, flame, and smoking. When the dose counter reaches “0” or three months have passed since you removed it from the foil bag, whichever comes first, throw it away.
The following side effects should be reported as soon as possible to a physician or other healthcare providers: allergic symptoms such as skin rash, hives, itching, or swelling of the face, lips, or tongue, as well as visual changes eye discomfort, heartbeat rhythmic shifts (trouble breathing; chest pain; dizziness; fast, irregular heartbeat; feeling faint or lightheaded, falls), elevated blood sugar (increased hunger, thirst or urination; unusually weak or tired, blurry vision), infection (fever, chills, cough, sore throat, discomfort or trouble passing urine) (fever, chills, cough, sore throat, pain or trouble passing urine), muscle ache and cramps thrush (white patches in the mouth or mouth sores), difficulty breathing, difficulty sleeping, unexpected weakness or fatigue
The Global formoterol budesonide market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Teva Pharma B.V.’s formoterol budesonide is a medication used to treat adult patients with asthma who would benefit from a combination product. Patients may use it for:
whose disease is satisfactorily controlled by treatment with corticosteroids and “long-acting beta-2 agonists” administered by inhalation; whose disease is insufficiently controlled by treatment with other asthma medications known as corticosteroids and “short-acting beta-2 agonists”
Adults with severe chronic obstructive pulmonary disease (COPD) who have experienced exacerbations (flare-ups) of the condition in the past despite regular medication can also use budesonide/formoterol Teva Pharma B.V. to alleviate their symptoms.
The airways and air sacs inside the lungs get harmed or obstructed as a result of the chronic condition COPD, making breathing difficult.
